Insighta
Insighta, a landmark Joint Venture between Prenetics (NASDAQ: PRE), and renowned scientist, Prof. Dennis Lo, aims to revolutionize multi-cancer early detection. Backed by world-class science from Prof. Lo, robust capital resources of US$100m from Prenetics, and led by successful entrepreneur Danny Yeung, the joint venture is poised to transform cancer screening. Insighta plans to introduce Presight for lung and liver cancers in 2025, and to expand with Presight One for 10+ cancers in 2027. Insighta presents an unprecedented opportunity to save lives and bolster Hong Kong's standing as a global hub for life sciences innovation.
insighta.comCompany Details
Founded
- 2023
Employees
- Between 10 - 50 employees
Raised
- $30,000,000
Public
- No
Acquired
- No
Founders
- Allen Chan
Company Collections
These are collections Insighta is a part of. Click on the collection name to view similar companies.
Insighta's Industries
Insighta Headquarters Location
Total Amount Raised: $30,000,000
Insighta Funding Rounds
Secondary Market
$30,000,000
Secondary Market Investors
Tencent
Insighta Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Insighta.